MediSave CDMP Expansion and the Preventative Emotional Support Gap

The new MediSave withdrawal limits in Singapore just made it easier to afford mental health care. But it covers clinical visits and medications, not the emotional distress that happens between them.

Singapore recently raised MediSave withdrawal limits for Chronic Disease Management Programme (CDMP) covered mental health conditions to $700–$1,000/year (Ministry of Health Singapore, 2026). We welcome the provided financing for doctor consultations and prescriptions. But the CDMP has a structural gap: it funds reactive treatment, not preventative care.

Research shows clinically significant psychological distress affects between 20–39% of breast cancer patients across symptom categories: 39% for non-specific distress, 34% for anxiety, 31% for post-traumatic stress, and 20% for depression (Fortin et al., 2021). Preventative emotional support is needed. It catches distress early — at 2 a.m., between appointments, or before it becomes a crisis. But it's not funded.

The clinical case for preventative emotional support

The gap between appointments isn't only a wellbeing concern. Depression is a documented risk factor for treatment non-adherence across clinical populations. In breast cancer specifically, depressive symptoms are a leading barrier to completing adjuvant endocrine therapy — a 2022 systematic review of 26 studies found adherence drops by an average of 25.5% from year 1 to year 5 (Yussof et al., 2022).

Anxiety drives scan avoidance, which delays follow-up imaging and worsens outcomes (de Vries et al., 2023).

A 2022 longitudinal study of cancer patients found that those who were diagnosed with depression after their cancer diagnosis and adhered poorly to psychiatric treatment had the greatest hazard of mortality (HR = 1.829, 95% CI: 1.687–1.984). Meanwhile, patients who adhered to psychiatric treatment after diagnosis had significantly lower hazard than patients without depression (HR = 0.702, 95% CI: 0.607–0.812) (Yen et al., 2022).

Preventative emotional support should be treated as an integral part of the holistic care pathway to treatment adherence and, ultimately, better survival outcomes and quality of life.

What we'd like to see next

CDMP expanding beyond reactive treatment funding to include preventative emotional support tools — digital or otherwise — that catch distress before it escalates.

Now is the time to advocate for what patients actually need between appointments.

---

References (APA)

1. Ministry of Health Singapore. (2026, April 7). Assessing out-of-pocket costs for outpatient mental health treatment across public and private settings [Parliamentary Q&A, Notice Paper No. 659, Q1245]. Government of Singapore. Link
2. Fortin, J., Leblanc, M., Elgbeili, G., Cordova, M. J., Marin, M. F., & Brunet, A. (2021). The mental health impacts of receiving a breast cancer diagnosis: A meta-analysis. British Journal of Cancer, 125, 1348–1359. Link
3. Yussof, I., et al. (2022). Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review. The Breast, 54, 268–275. Link
4. Yen, Y.-C., Huang, C.-Y., Chan, H.-W., Wang, Y.-Y., Changchien, T.-C., Wang, D.-W., Lin, P.-C., Chang, T.-T., & Chiu, Y.-W. (2022). Longitudinal association of universal screening and treatment for major depressive disorder with survival in cancer patients. Journal of Personalized Medicine, 12(8), 1213. Link
5. de Vries, H. M., Mosher, C. E., Gundersen, D. A., Stump, T. E., Bui, A. H., & Champion, V. L. (2023). Scanxiety among adults with cancer: A scoping review to guide research and interventions. Cancers, 15(5), 1381. Link
6. Tewari, A. S., Hashim, N. B., & Husain, R. (2023). The prevalent factors of anxiety in women undergoing mammography. Frontiers in Psychiatry, 14, 1085115. Link

#PsySymbiosis · #MentalHealth · #HealthcareAI · #DigitalHealth · #WomenInTech · #SingaporeHealth